GB0314049D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0314049D0 GB0314049D0 GBGB0314049.8A GB0314049A GB0314049D0 GB 0314049 D0 GB0314049 D0 GB 0314049D0 GB 0314049 A GB0314049 A GB 0314049A GB 0314049 D0 GB0314049 D0 GB 0314049D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314049.8A GB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
| PCT/SE2004/000967 WO2004111038A1 (en) | 2003-06-18 | 2004-06-16 | 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314049.8A GB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0314049D0 true GB0314049D0 (en) | 2003-07-23 |
Family
ID=27636731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0314049.8A Ceased GB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0314049D0 (en) |
| WO (1) | WO2004111038A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003275242B2 (en) | 2002-09-27 | 2010-03-04 | Merck Sharp & Dohme Corp. | Substituted pyrimidines |
| CN101132780A (en) * | 2005-02-15 | 2008-02-27 | 爵士制药公司 | Dosage form and method for sustained release of substituted pyrazine compound |
| DK1868999T3 (en) | 2005-04-06 | 2009-08-17 | Hoffmann La Roche | Pyridine-3-carboxamide derivatives as reverse CB1 agonists |
| US7629346B2 (en) | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
| US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
| EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
| WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| CA2741672A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| WO2011106273A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
| EA025380B1 (en) | 2011-02-25 | 2016-12-30 | Мерк Шарп Энд Домэ Корп. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| KR20150036245A (en) | 2012-08-02 | 2015-04-07 | 머크 샤프 앤드 돔 코포레이션 | Antidiabetic tricyclic compounds |
| RU2015140066A (en) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | ANTI-DIABETIC BICYCLIC COMPOUNDS |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06501926A (en) * | 1990-08-06 | 1994-03-03 | 藤沢薬品工業株式会社 | heterocyclic compound |
| FR2713225B1 (en) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | Substituted N-piperidino-3-pyrazolecarboxamide. |
| CN1205188C (en) * | 2000-03-23 | 2005-06-08 | 索尔瓦药物有限公司 | 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity |
| SE0104332D0 (en) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| SE0104330D0 (en) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-18 GB GBGB0314049.8A patent/GB0314049D0/en not_active Ceased
-
2004
- 2004-06-16 WO PCT/SE2004/000967 patent/WO2004111038A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004111038A1 (en) | 2004-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0303910D0 (en) | Therapeutic agents | |
| GB0308318D0 (en) | Therapeutic agents | |
| GB0314079D0 (en) | Therapeutic agents | |
| GB0314057D0 (en) | Therapeutic agents | |
| GB0313250D0 (en) | Therapeutic agents | |
| GB0314261D0 (en) | Therapeutic agents | |
| GB0316237D0 (en) | Therapeutic agents | |
| GB0316232D0 (en) | Therapeutic agents | |
| GB0314049D0 (en) | Therapeutic agents | |
| GB0314129D0 (en) | Therapeutic agents | |
| GB0311859D0 (en) | Therapeutic agents | |
| GB0311201D0 (en) | Therapeutic agents | |
| GB0301350D0 (en) | Therapeutic agents | |
| GB0314136D0 (en) | Therapeutic agents | |
| GB0314130D0 (en) | Therapeutic agents | |
| GB0314260D0 (en) | Therapeutic agents | |
| GB0314075D0 (en) | Therapeutic agents | |
| GB0314134D0 (en) | Therapeutic agents | |
| GB0304524D0 (en) | Therapeutic agents | |
| GB0314131D0 (en) | Therapeutic agents | |
| GB0314078D0 (en) | Therapeutic agents | |
| GB0305283D0 (en) | Therapeutic agents | |
| GB0305822D0 (en) | Therapeutic agents | |
| GB0313646D0 (en) | Therapeutic agents | |
| GB0314042D0 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |